**Tamodex** is a medication primarily used in the treatment of breast cancer, particularly in postmenopausal women. Its active ingredient is **tamoxifen**, which belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). Tamodex works by blocking estrogen receptors on breast cancer cells, inhibiting their growth and proliferation. This makes it effective for hormone receptor-positive breast cancers.
The drug is often prescribed for both the adjuvant treatment of early-stage breast cancer and the treatment of metastatic breast cancer. It is typically administered orally in tablet form, and the dosage varies based on individual patient needs and treatment protocols. Common side effects may include hot flashes, mood swings, and nausea, while more severe risks can include blood clots and uterine cancer.
Tamodex treatment usually lasts for several years, depending on the specific case and response to therapy. Regular monitoring by a healthcare provider is essential to manage any side effects and assess the effectiveness of the treatment.